- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Zydus Wellness net sales up by 9.6 percent to Rs 778 crores in Q4
Ahmedabad: Zydus Wellness Ltd. has reported net sales of Rs 778 crores, up by 9.6% for the fourth quarter ended March 31, 2024.
The company registered growth in EBIDTA of 12.2% y-o-y basis to Rs. 162 crores. The Company reported Profit after Tax of Rs.150 crores. Adjusted PAT after eliminating exceptional items and one-time deferred tax assets impact from comparable quarter of previous year, grew by 24.7% on a year-on-year basis. Total income from operations increased by 3.2 % y-o-y to 2328 crores during the financial year. Reported net profit stood at 267 crores for the financial year.
With the continued thrust on marketing initiatives, several key brands including Glucon-D, Everyuth, and Nycil continued to perform well during the quarter. The personal care portfolio comprising of Everyuth and Nycil brand drove the growth for the quarter with 23% growth on a year-on-year basis.
The Food and Nutrition portfolio also registered a mid-single digit growth. All brands contributed to the performance with overall volume growing by close to 6 percent. The Sugar Free brand maintained its leadership in the sugar substitute category with a market share of 95.9 %*.
The Group has launched a new brand, I’mlite, a unique formulation of sugar blended with stevia to offer consumers 50% less calories than regular sugar. Glucon-D continues to maintain its number one position with 59.5%* market share at MAT level. The brand has entered the Ready to Drink beverage category with the pilot launch of Glucon-D Activors Electrolyte Energy drink in couple of key states during the quarter.
During the quarter, the Nutrition Drink Category has registered a growth of 6.4 %* at MAT level. Complan’s market share stood at 4.3%* . Nycil continues to be at number one position with a market share of 35%* in the prickly heat powder category. Everyuth Scrub has maintained its leadership position with a market share of 45.6 %* in the facial scrub category which is an increase of 369 basis points over the same period last year. Everyuth Peel off has held on to its number one position with a market share of 80.2%* , in the Peel off category which is an increase of 174 basis points over the same period last year. In the facial cleansing segment, Everyuth stood at the 5th position with a market share of 6.5%* .
Read also: Zydus Lifesciences Dexamethasone Tablets bags USFDA okay
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751